'We're pretty cheap at the moment' - Cybin CEO Doug Drysdale

19 set 2024 · 33 min. 35 sec.
'We're pretty cheap at the moment' - Cybin CEO Doug Drysdale
Descrizione

Cybin CEO Doug Drysdale talks to https://seekingalpha.com/author/jason-najum?source=ie_podcast:were_pretty_cheap_cybin_ceo_doug_drysdale about transforming treatment of mental health disorders with psychedelics (0:45). CYB003, Phase 2 results for depression, moving into Phase 3 (3:00). How deuterated...

mostra di più
Cybin CEO Doug Drysdale talks to Jason Najum about transforming treatment of mental health disorders with psychedelics (0:45). CYB003, Phase 2 results for depression, moving into Phase 3 (3:00). How deuterated psilocin differentiates Cybin from competiton (10:00). IP and patents - critical to ROI (12:45). Esketamine and is JNJ's Spravato blazing a trail for psychedelics? (14:15) FDA challenges and Lykos lessons (21:20). Strong balance sheet will get it through Phase 3 data (25:50) Stock consolidation and attracting new buyers (30:35).

Episode transcripts

Show Notes:
Imran Khan On Psychedelics - More We Don't Know Than We Do
Psychedelic Stocks: Focus On Their Cash
FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged
De-Risking Psychedelics: Compass Pathways, Cybin And Atai

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
mostra meno
Informazioni
Autore Seeking Alpha
Organizzazione Seeking Alpha
Sito seekingalpha.com
Tag

Sembra che non tu non abbia alcun episodio attivo

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti

Corrente

Copertina del podcast

Sembra che non ci sia nessun episodio nella tua coda

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti

Successivo

Copertina dell'episodio Copertina dell'episodio

Che silenzio che c’è...

È tempo di scoprire nuovi episodi!

Scopri
La tua Libreria
Cerca